Pharma BD Deal Intelligence
Stryker buys Gaymar Industries for $150 million, broadening its capital and disposable product portfolio in pressure ulcer management and temperature…
MedCity News framed the $150M Gaymar acquisition as a logical extension of a 10-year OEM relationship and an attractive bolt-on for Stryker's Medical division…
Stryker announces definitive agreement to acquire privately held Gaymar Industries for approximately $150 million in an all-cash transaction, expanding into…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Stryker to acquire privately held Gaymar Industries for $150M cash, formalizing 10-year OEM partnership in pressure ulcer/temperature management devices.
Assessment window: 10yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Stryker Corporation / Gaymar Industries (this deal) | 2010 | $150M | 54 |
| Stryker Corporation / MAKO Surgical Corp. | 2013 | $1.6B | 91 |
| Stryker Corporation / Wright Medical Group N.V. | 2019 | $5.4B | 81 |
| Stryker Corporation / Trauson Holdings Company Limited | 2013 | $764M | 37 |
| Stryker Corporation / Inari Medical, Inc. | 2025 | $4.9B | — |
| Watson Pharmaceuticals (Actavis Inc.) / Actavis plc | 2012 | $5.9B | 97 |
| Kohlberg Kravis Roberts & Co. / PRA International (Genstar Capital) | 2013 | $1.3B | 91 |
← Browse all deals · How we score deals
More: 2010 deals · Stryker Corporation deals · Other deals